A Japanese researcher has developed a drug that is said to cure cancer. He explained that the drug uses a virus to attack the brain tumor and could be used to cure other types of cancer.
This drug was brought out during an online conference by professor Todo Tomoki at the University of Tokyo Institute of Medical Science. He said that the drug uses herpes virus that is genetically engineered to replicate in cancer cells and destroy them.
The drug was approved last month by Japan's health ministry for a short term acknowledging it's effectiveness on gliomas a malignant brain tumor.
Professor Todo said that the one year survival rate of patients with the brain tumor after receiving standard therapy such as surgery was only 15 percent. He recommended the virus drug as the rate for patients given the drug was 93.2 percent in clinic trials.
The professor says that he has worked with the maker of the drugs and the government to open its way. He added that he was holding clinical trials with patients suffering from various types of cancer to accumulate data.
Content created and supplied by: Donminu (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More